Correlation Between Arcus Biosciences and Cidara Therapeutics
Can any of the company-specific risk be diversified away by investing in both Arcus Biosciences and Cidara Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcus Biosciences and Cidara Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcus Biosciences and Cidara Therapeutics, you can compare the effects of market volatilities on Arcus Biosciences and Cidara Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcus Biosciences with a short position of Cidara Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcus Biosciences and Cidara Therapeutics.
Diversification Opportunities for Arcus Biosciences and Cidara Therapeutics
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Arcus and Cidara is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Arcus Biosciences and Cidara Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cidara Therapeutics and Arcus Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcus Biosciences are associated (or correlated) with Cidara Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cidara Therapeutics has no effect on the direction of Arcus Biosciences i.e., Arcus Biosciences and Cidara Therapeutics go up and down completely randomly.
Pair Corralation between Arcus Biosciences and Cidara Therapeutics
Given the investment horizon of 90 days Arcus Biosciences is expected to generate 2.61 times less return on investment than Cidara Therapeutics. But when comparing it to its historical volatility, Arcus Biosciences is 1.92 times less risky than Cidara Therapeutics. It trades about 0.14 of its potential returns per unit of risk. Cidara Therapeutics is currently generating about 0.19 of returns per unit of risk over similar time horizon. If you would invest 1,869 in Cidara Therapeutics on September 25, 2024 and sell it today you would earn a total of 474.00 from holding Cidara Therapeutics or generate 25.36% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Arcus Biosciences vs. Cidara Therapeutics
Performance |
Timeline |
Arcus Biosciences |
Cidara Therapeutics |
Arcus Biosciences and Cidara Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Arcus Biosciences and Cidara Therapeutics
The main advantage of trading using opposite Arcus Biosciences and Cidara Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcus Biosciences position performs unexpectedly, Cidara Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cidara Therapeutics will offset losses from the drop in Cidara Therapeutics' long position.Arcus Biosciences vs. Fate Therapeutics | Arcus Biosciences vs. Caribou Biosciences | Arcus Biosciences vs. Karyopharm Therapeutics | Arcus Biosciences vs. X4 Pharmaceuticals |
Cidara Therapeutics vs. Fate Therapeutics | Cidara Therapeutics vs. Caribou Biosciences | Cidara Therapeutics vs. Karyopharm Therapeutics | Cidara Therapeutics vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
CEOs Directory Screen CEOs from public companies around the world | |
Stocks Directory Find actively traded stocks across global markets |